News on Approval of the First Oral Preventive Therapy for Hereditary Angioedema and More development of the first treatment for Niemann-Pick disease to approval of a medication that reduces the risk of cardiovascular death and heart failure hospitalization, learn about the most impactful changes at each stage of the drug pipeline in this edition of Perspective on the Rx Pipeline.

Perspective on the Rx Pipeline

Clinical Pipeline

Within the extensive pipeline of drugs preparing for market launch, these are the two most notable drugs plan sponsors should be aware of:

Drug Approvals

Eight drugs recently approved by the FDA include:

New Indications

Drugs that have gained FDA approval for the treatment of additional diseases and/or conditions and have potential to be impactful include:

Generic Approvals

There are several new generic product offerings to the marketplace, including drugs for the treatment of osteoarthritis pain, prostate cancer and bipolar disorder. A review of generic launches, including biosimilars, is provided in the full report.

Download the full report for more information, including important safety updates and drug shortages and discontinuations.